Epidemiology of and preventive measures for multiresistant pathogens;Epidemiologie von und Präventionsmaßnahmen bei multiresistenten Erregern

Ophthalmologe

Volumn 107, Issue 4, 2010, Pages 313-317

  Kruse, E B ^a   Dettenkofer, M ^b  

^a Deutsches Beratungszentrum Fãr Hygiene   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Epidemiology; ESBL; MRSA; Multidrug resistant organisms; VRE

Indexed keywords

ARTICLE; BACTERIAL EYE INFECTION; EPIDEMIC; HEALTH SURVEY; HUMAN; INCIDENCE; INTERNATIONAL COOPERATION; METHODOLOGY; MULTIDRUG RESISTANCE; RISK ASSESSMENT; RISK FACTOR; STATISTICS; DISEASE OUTBREAKS; EYE INFECTIONS, BACTERIAL; PROCEDURES; STATISTICS AND NUMERICAL DATA;

DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EYE INFECTIONS, BACTERIAL; HUMANS; INCIDENCE; INTERNATIONALITY; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS;

EID: 77954031177     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-009-2074-2     Document Type: Article

References (48)

1. Arpin C, Rogues AM, Kabouche S et al (2000) Prospective survey of colonization and infection caused by SHV-4 producing Klebsiella pneumoniae in a neurosurgical intensive care unit. Epidemiol Infect 124(3): 401-408.
2. Austin DJ, Bonten MJ, Weinstein RA et al (1999) Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence and the impact of infection control programs. Proc Natl Acad Sci U S A 96(12): 6908-6913.
3. Barber M (1961) Methicillin-resistant staphylococci. J Clin Pathol 14: 385-393.
4. Bialasiewics AA, Welt R (1991) Präoperative mikrobiologische Diagnostik vor elektiven intraokularen Eingriffen und Infektionsprophylaxe mit Tobramycin-Augentropfen. Ergebnis einer multizentrischen Studie. Klin Monatsbl Augenheilkd 198: 87-93.
5. Blomquist PH (2006) Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 104: 322-345.
6. Bonten MJ, Hayden MK, Nathan C et al (1996) Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348(9042): 1615-1619.
7. Bonten MJ, Mascini EM, Willems R et al (2000) Wat te doen als men vancomycineresistente enterokokken aantreeft? Ned Tijdschr Geneeskd 144(53): 2545-2549.
8. Boyce JM (2002) Understanding and controlling methicillin-resistant Staphylococcus aureus infections. Infect Control Hosp Epidemiol 23(9): 491-494.
9. Boyce JM, Havill NL, Kohan C et al (2004) Do infection control measures work for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 25(5): 395-401.
10. Chuang YY, Huang YC, Lin CH et al (2009) Epidemiological investigation after hospitalising a case with pandrug-resistant Acinetobacter baumannii infection. J Hosp Infect 72(1): 30-35.
11. Coello R, Glynn JR, Gaspar C et al (1997) Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect 37(1): 39-46.
12. Dettenkofer M, Widmer AF, Kern WV (2008) MRSA und andere multiresistente Erreger: ein Problem zunehmend auch in der ambulanten Medizin. Dtsch Med Wochenschr 133(8): 370-371.
13. The EARSS Management Team (2008) EARSS Annual Report 2007. http://www. rivm. nl/earss/Images/EARSS%202007_FINAL_tcm61-55933. pdf.
14. Esmaeli B, Holz ER, Ahmadi MA et al (2003) Endogenous endophthalmitis secondary to vancomycin-resistant enterococci infection. Retina 23: 118-119.
15. Falagas ME, Karageorgopoulos DE (2009) Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect 73(4): 345-354.
16. Freidlin J, Acharya N, Lietman TM et al (2007) Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol 144(2): 313-315.
17. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E (2006) Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368(9538): 874-885.
18. Haley RW, Hightower AW, Khabbaz RF et al (1982) The emergence of methicillin-resistant Staphylococcus aureus infection in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med 97: 297-308.
19. Hanberger H, Arman D, Gill H et al (2009) Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control. Intensive Care Med 35(1): 91-100.
20. Heeg P, Schröppel K (2009) Infektionen durch Methicillin-resistente Staphylococcus aureus (MRSA). Med Klin 104(6): 464-473.
21. Horio N, Horiguchi M, Murakami K et al (2000) Stenotrophomonas maltophilia endophthalmitis after intraocular lens implantation. Graefes Arch Clin Exp Ophthalmol 238(4): 299-301.
22. Huang SS, Platt R (2003) Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36(3): 281-285.
23. Huang SS, Yokoe DS, Hinrichsen VL et al (2006) Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 43(8): 971-978.
24. Huycke MM, Sahm DF, Gilmore MS (1998) Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis 4: 239-249.
25. Jevons MP (1961) Celbenin-resistant staphylococci. BMJ 1: 124-125.
26. Leclerq R (2009) Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci. Clin Microbiol Infect 15: 224-231.
27. Lister PD, Wolter DJ, Hanson ND (2009) Antibacterial-resistant pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22(4): 582-610.
28. Maguen E, Morgan MA (2007) A case of Vancomycin-resistant enterococcus conjunctivitis and its clinically successful topical treatment. Cornea 26: 223-224.
29. Mangini E, Segal-Maurer S, Burns J et al (2007) Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol 28(11): 1261-1266.
30. Mascini EM, Bonten MJ (2005) Vancomycin-resistant enterococci: consequences for therapy and infection control. Clin Microbiol Infect 11(Suppl 4): 43-56.
31. Ofner-Agostini M, Varia M, Johnston L et al (2007) Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals. Am J Infect Control 35(9): 563-568.
32. Patel JB, Gorwitz RJ, Jernigan JA (2009) Mupirocin resistance. Clin Infect Dis 49(6): 935-941.
33. Paterson DL, Mulazimoglu L, Casellas JM et al (2000) Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 30(3): 473-478.
34. Peña C, Pujol M, Ricart A et al (1997) Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 35(1): 9-16.
35. Perencevich EN, Fisman DN, Lipsitch M et al (2004) Projected benefits of active surveillance for vancomycin-resitant enterococci in intensive care units. Clin Infect Dis 38(8): 1108-1115.
36. Peters G, Becker K (1996) Epidemiology, control and treatment of methicillin-resistant Staphylococcus aureus. Drugs 52(Suppl 2): 50-54.
37. Rathod D, Lugmani N, Webber SK, Hosein IK (2009) Survey of Methicillin-resistant Staphylococcus aureus policies in UK eye departments. J Hosp Infect 72(4): 314-318.
38. Roghmann MC, McCarter RJ Jr, Brewrink J et al (1997) Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia. Clin Infect Dis 25(5): 1056-1059.
39. Schulze-Röbbecke R (2009) Standardmaßnahmen zur Prävention der Übertragung nosokomialer Infektionen - Standardhygiene, Basishygiene. Krankenhaushygiene up2date 4(3): 193-207.
40. Shanmuganathan VA, Armstrong M, Buller A, Tullo AB (2005) External ocular infections due to Methicillin-resistant Staphylococcus aureus (MRSA). Eye 19(3): 284-291.
41. Sievert DM, Rudrik JT, Patel JB et al (2008) Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 46(5): 668-674.
42. Solomon R, Donnenfeld ED, Perry HD et al (2007) Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery. Am J Ophthalmol 143(4): 629-634.
43. Sotozono C, Inagaki K, Fujita A et al (2002) Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea. Cornea 21(7Suppl): S94-S101.
44. Tang CW, Cheng CK, Lee TS (2007) Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci. Can J Ophthalmol 42: 477-478.
45. Tenover FC, Hughes JM (1996) The challenges of emerging infectious diseases: development and spread of multiply resistant bacterial pathogens. JAMA 275: 300-304.
46. Rijen M van, Bonten M, Wenzel R, Kluytmans J (2008) Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 4: CD006216.
47. Voss A, Loeffen F, Bakker J et al (2005) Methicillin-resitant Staphylococcus aureus in pig farming. Emerg Infect Dis 11: 1965-1966.
48. Wisplinghoff H, Bischoff T, Talient SM et al (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39(3): 309-317.